46 Xx Disorder Of Gonadal Development C5680950
A variation in typical female reproductive development involving chromosomal, gonadal, or anatomical differences. Medical management is individualized based on specific circumstances.
Key facts at a glance
- ICD-10
- Q55.9
- ICD-11
- LA00.0
- Body system
- reproductive
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Gonadoblastoma Risk
Increased risk of developing benign or malignant tumors in dysgenic gonadal tissue.
URGENT: Any pelvic pain, mass, or abnormal bleeding requires immediate medical evaluation; regular surveillance is essential.
Cardiovascular Anomalies
Some individuals may have associated heart or blood vessel abnormalities.
URGENT: Chest pain, shortness of breath, or fainting requires immediate emergency evaluation.
Primary Amenorrhea
(reproductive)Complete absence of menstrual periods by age 15 or after three years of no menstruation following development of secondary sexual characteristics.
Frequency: 80-90% of patients
Delayed or Absent Puberty
(reproductive)Failure to develop secondary sexual characteristics such as breast development, growth spurt, or body hair by the expected age.
Frequency: 75-85% of patients
Gonadal Dysgenesis
(reproductive)Underdeveloped or abnormal gonadal tissue that may not function properly to produce hormones or gametes.
Frequency: 60-70% of patients
Primary Infertility
(reproductive)Inability to conceive a child naturally due to absent or non-functional gonadal tissue.
Frequency: 70-80% of patients
Ambiguous Genitalia
(reproductive)External genitalia that does not clearly appear typically male or female at birth.
Frequency: 20-30% of patients
Hormonal Imbalance
(endocrine)Abnormal levels of reproductive hormones such as estrogen, testosterone, FSH, and LH due to gonadal dysfunction.
Frequency: 60-75% of patients
Psychological Distress
(psychiatric)Emotional challenges including anxiety, depression, or identity concerns related to diagnosis and reproductive health.
Frequency: 50-60% of patients
Hypoplastic Uterus
(reproductive)Underdeveloped or small uterus, which may affect menstrual function and fertility potential.
Frequency: 5-10% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Hormone Replacement Therapy
Estrogen and progesterone replacement therapy to support secondary sexual characteristics and bone health. This is typically initiated at puberty age and continued throughout life to maintain hormonal balance and prevent osteoporosis.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Psychological Counseling and Support
Specialized counseling addressing gender identity, sexual development concerns, and emotional adjustment. Family counseling is often beneficial to support understanding and acceptance.
Additional treatment options
Endocrine Monitoring Program
Regular monitoring of hormone levels, bone density, and metabolic markers to ensure optimal dosing and early detection of complications.
monitoringGonadectomy if indicated
Surgical removal of streak gonads or gonads with malignancy risk when determined necessary by the healthcare team. Decision made collaboratively with patient and family.
surgicalFertility and Reproductive Counseling
Comprehensive counseling about reproductive options including assisted reproductive technologies, egg donation, or adoption. Addresses psychosocial aspects of family building.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is 46 Xx Disorder Of Gonadal Development C5680950?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Hughes IA, Houk C, Ahmed SF, Lee PA, LWPES1/ISS2 Consensus Group. Consensus statement on management of intersex disorders. Archives of Disease in Childhood. 2006.
Lee PA, Houk CP, Ahmed SF, Hughes IA. Consensus statement on management of intersex disorders. International Journal of Pediatric Endocrinology. 2007.
Bashamboo A, McElreavey K. Gene mutations involved in testicular development and 46,XX testicular disorders of sex development. Current Opinion in Endocrinology, Diabetes and Obesity. 2016.
Grinspon RP, Rey RA. Molecular pathology of disorders of sex development. Molecular and Cellular Endocrinology. 2021.
Feng R, Sang Q, Kuang Y, et al. Mutations in BMP15 and BMP15-like genes are associated with primary ovarian insufficiency. New England Journal of Medicine. 2015.
Mendoza-Torres E, Riquelme J, Pommer R. BMP15 and FOXL2 in ovarian development and disease. Frontiers in Cell and Developmental Biology. 2022.
Melmed S, et al. Williams Textbook of Endocrinology. Elsevier. 2020.
International Consensus Conference on Intersex. Consensus statement on disorders of sex development. 2006.
Jorgensen A, Mitchell G, Duno J, Gravholt CH. Disorders of Sex Development: Genetic and Molecular Basis. Endocrinology and Metabolism Clinics of North America. 2020.
Medication Comparisons
Compare medications used to treat 46 Xx Disorder Of Gonadal Development C5680950. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy